Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by tradingsteveon Sep 09, 2010 1:29pm
633 Views
Post# 17430056

RE: The way I see it...

RE: The way I see it...Good, reasoned comments......I've certainly never been accused of being an SSS bull, but I remain hopeful of their prospects......today's news wasn't groundbreaking or anything great, but it shows the company is progressing and moving on....ultimately the FDA will do what it will do with regard to the Stroke trial, but when you consider the upcoming TBI study, it is starting to look like there is a little more light at the end of the tunnel.....

GLTA
Bullboard Posts